News Release
Oct. 10, 2024
Infection from COVID-19 appeared to significantly increase the risk of heart attack, stroke, and death for up to three years among unvaccinated people early in the pandemic when the original SARS-CoV-2 virus strain emerged, according to a National Institutes of Health (NIH)-supported study. The findings, among people with or without heart disease, confirm previous research showing an associated higher risk of cardiovascular events after a COVID-19 infection but are the first to suggest the heightened risk might last up to three years following initial infection, at least among people infected in the first wave of the pandemic.
News Release
Oct. 9, 2024
The National Institutes of Health has launched a nationwide consortium to address the dramatic rise in youth diagnosed with type 2 diabetes over the past two decades, a trend that is expected to continue. The effort aims to advance understanding of the biologic, social, and environmental drivers of youth-onset type 2 diabetes, with the goals of determining which children are at highest risk for developing the disease and how to better prevent, screen for, and manage type 2 diabetes in young people.
News Release
Sept. 17, 2024
Adults who use the prescription drug metformin to treat their type 2 diabetes have a lower risk of developing long COVID or dying after a COVID-19 infection than people with diabetes who take other anti-diabetes medications, according to a large study supported by the National Institutes of Health.
News Release
April 4, 2024
Researchers have shown that dangerous cysts, which form over time in polycystic kidney disease (PKD), can be prevented by a single normal copy of a defective gene. This means the potential exists that scientists could one day tailor a gene therapy to treat the disease. They also discovered that a type of drug, known as a glycoside, can sidestep the effects of the defective gene in PKD. The discoveries could set the stage for new therapeutic approaches to treating PKD, which affects millions worldwide.
News Release
Feb. 27, 2024
People with type 2 diabetes who underwent bariatric surgery achieved better long-term blood glucose control compared to people who received medical management plus lifestyle interventions according to a new study supported by the National Institutes of Health.
News Release
Jan. 30, 2024
Researchers at the National Institutes of Health observed rapid and distinct immune system changes in a small study of people who switched to a vegan or a ketogenic (also called keto) diet. Scientists closely monitored various biological responses of people sequentially eating vegan and keto diets for two weeks, in random order.
Research Update
Jan. 10, 2024
NIDDK-supported research is improving the assessment of kidney function by providing accurate alternatives to race-based tools.
Research Update
Jan. 10, 2024
2023 marked the 50th anniversary of the NIDDK-supported Diabetes Research Centers, which have transformed the field of diabetes research.
News Release
Jan. 10, 2024
Diabetes in America is the NIDDK’s compilation and assessment of epidemiologic, public health, clinical research, and clinical trial data focused on diabetes. This updated resource, developed by researchers at NIDDK and leading diabetes experts from around the country and world, is a one-stop source for crucial scientific information on diabetes, its complications and treatment, health care utilization, and diabetes prevention in the United States.
Research Update
Jan. 10, 2024
NIDDK supports research to develop automated, more reliable measurement tools for kidney stone detection.
Research Update
Jan. 10, 2024
Decades of NIH-supported research has led to FDA approval of islet transplantation for a limited subset of people with type 1 diabetes.
Research Update
Jan. 10, 2024
The NIDDK-supported Lower Urinary Tract Symptoms Network has developed tools to better understand the full spectrum of lower urinary tract symptoms.
Research Update
Jan. 10, 2024
NIDDK continues to support a highly collaborative research program to better understand NAFLD/NASH and to identify new treatment approaches.
Research Update
Jan. 10, 2024
NIDDK supports a wide range of research on the liver, including large research networks on specific types of liver disease.
Research Update
Jan. 10, 2024
In 2023, the Special Statutory Funding Program for Type 1 Diabetes Research (Special Diabetes Program) celebrated 25 years of research progress.
News Release
July 19, 2023
A study funded by the NIH created the most comprehensive atlas of the human kidney to advance progress in understanding and treating kidney disease. The Kidney Tissue Atlas marks an important milestone for the multicenter study, called the Kidney Precision Medicine Project (KPMP), which began in 2017 with the aim of improving treatment for kidney disease.
Research Update
June 29, 2023
New biomarkers have been identified that can predict early stages of type 1 diabetes.
Research Update
May 31, 2023
Research showed that eating adequate dietary fiber and minimally processed foods can remodel human gut microbiomes and improve energy balance.
Research Update
May 25, 2023
Researchers identified biological pathways linking stress to worsening inflammatory bowel disease symptoms.
Research Update
May 8, 2023
Studying the genomes from people of East Asian and European ancestry together has identified new genetic risk factors for inflammatory bowel disease.
Research Update
May 3, 2023
Researchers working with mice identified proteins that link physical exercise with some of its beneficial effects.
Research Update
May 1, 2023
A clinical trial of abatacept demonstrated that the immune-targeting drug did not delay type 1 diabetes diagnosis.
News Release
April 27, 2023
A study supported by the National Institutes of Health found that people who experienced acute kidney injury (AKI) during a hospitalization, including those admitted with AKI or who developed AKI in the hospital, were more likely to revisit the hospital or die shortly after discharge, compared to people hospitalized without AKI. AKI is a sudden loss of kidney function that usually lasts for a short time. The research, funded by NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), was published in the American Journal of Kidney Diseases.
Research Update
April 24, 2023
Women with type 2 diabetes continue to carry a greater burden of cardiometabolic and socioeconomic risk factors than men.
Research Update
April 19, 2023
Scientists in NIDDK's Intramural Research Program have found new insights into how damaged DNA is repaired.
Research Update
April 17, 2023
Scientists have learned how eating and fasting prompts mice’s cells to increase or decrease insulin secretion by changing gene activity.
Research Update
April 6, 2023
New research in mice identified a genetic factor that may shed light on why some people with diabetes are prone to diabetic kidney disease.
Research Update
March 23, 2023
The DNA building block thymidine is an important regulator of telomere length, and this finding may lead to new therapies for telomere-related diseases.
Research Update
March 22, 2023
In mice, gastric bypass surgery reprograms the body’s day/night “clock”, affecting eating patterns and improving glucose metabolism.
News Release
March 15, 2023
Artificial pancreas technology improved blood glucose control in young children between ages 2 and 6 with type 1 diabetes, according to the results of the Pediatric Artificial Pancreas (PEDAP) Trial, a 13-week randomized controlled trial conducted at three pediatric diabetes centers across the United States.
Research Update
March 13, 2023
A research study revealed how cellular stress in the mouse intestinal lining is linked to chronic inflammatory diseases.
Research Update
March 7, 2023
Researchers studied the effects of an FDA mandate limiting the amount of acetaminophen in combination opioid- acetaminophen pain relievers.
Research Update
Feb. 28, 2023
Diabetes diagnoses continue to rise in young people in the U.S., especially among racial and ethnic minority youth.
News Release
Feb. 7, 2023
Findings from NIH-supported clinical trial showed early treatment of diabetes slows progression to severe disease, but it did not improve visual acuity compared with treating more severe disease once it developed.
Research Update
Jan. 17, 2023
Researchers analyzed symptoms following placement of stents after urinary stone surgery, aiming to understand risk factors for bothersome symptoms.
News Release
Jan. 5, 2023
A research team supported by the National Institutes of Health has developed a new approach to better understand the biology of polycystic kidney disease (PKD), and often-life-threatening genetic disorder that affects millions worldwide. Scientists combined two ways to model the disorder — organ-in-a-dish and organ-on-a-chip technologies — to show the role of glucose, a sugar commonly found in blood, in forming PKD cysts.
Research Update
Jan. 4, 2023
Listening in on how liver cells communicate amongst themselves led to discovery of new therapeutic targets for an advanced stage of nonalcoholic fatty liver disease.
News Release
Dec. 29, 2022
The number of young people under age 20 with diabetes in the United States is likely to increase more rapidly in future decades, according to a new modeling study published today in Diabetes Care.
Research Update
Dec. 27, 2022
Researchers have clarified what genetic variations can cause polycystic kidney disease in people.
Research Update
Dec. 23, 2022
Organ-on-a-chip technology has provided new insight into how glucose uptake affects cyst formation within the kidney.
Research Update
Dec. 23, 2022
A combination treatment regimen could increase long-term clearance of the hepatitis B virus.
Research Update
Dec. 15, 2022
Recent findings about connections between the gut and the liver in hepatitis C could lead to new treatments for liver disease.
Research Update
Dec. 14, 2022
Scientists discovered that, in mice, the gut microbiome influences brain activity contributing to motivation to exercise.
Research Update
Nov. 9, 2022
Treating the rare genetic disorder Pompe disease in utero may halt prenatal organ damage and improve health after birth.
News Release
Nov. 2, 2022
Taking a personalized approach to kidney disease screening for people with type 1 diabetes (T1D) may reduce the time that chronic kidney disease (CKD) goes undetected, according to a new analysis performed by the Epidemiology of Diabetes Interventions and Complications study group, which is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. The finding, published in Diabetes Care, provides the basis for the first evidence-based kidney screening model for people with T1D.
Research Update
Oct. 24, 2022
Improvements offer ways to simultaneously track the activity of multiple genes faster and more cheaply.
Research Update
Oct. 20, 2022
Mouse study revealed why eating late at night can be linked to weight gain and metabolic disease.
Research Update
Oct. 19, 2022
New research using two mouse models has investigated how different types of cells respond to kidney injuries.
Research Update
Oct. 14, 2022
New research in mice points to a possible connection between nerves, intestinal mucus, and gastrointestinal inflammation.
Research Update
Oct. 13, 2022
Researchers have used new mini-livers or organoids to study fatty liver disease with or without type 2 diabetes.
